MYIA
HZNP

Mount Yale Investment Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Mount Yale Investment Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-9,236
Closed -$1.05M – 540
2022
Q4 		$1.05M Sell
9,236
-488
-5% -$40.5K 0.12% 177
2022
Q3 		$602K Sell
9,724
-494
-5% -$34.5K 0.08% 246
2022
Q2 		$815K Sell
10,218
-629
-6% -$59.6K 0.1% 197
2022
Q1 		$1.14M Sell
10,847
-1,108
-9% -$108K 0.12% 178
2021
Q4 		$1.29M Sell
11,955
-174
-1% -$19K 0.13% 166
2021
Q3 		$1.33M Sell
12,129
-146
-1% -$15.2K 0.15% 146
2021
Q2 		$1.15M Sell
12,275
-1,654
-12% -$152K 0.14% 158
2021
Q1 		$1.28M Sell
13,929
-591
-4% -$49.9K 0.17% 127
2020
Q4 		$1.06M Sell
14,520
-1,226
-8% -$91.1K 0.15% 157
2020
Q3 		$1.22M Sell
15,746
-1,888
-11% -$130K 0.17% 127
2020
Q2 		$980K Buy
17,634
+9,941
+129% +$425K 0.18% 127
2020
Q1 		$228K Buy
7,693
+1,273
+20% +$43.1K 0.05% 259
2019
Q4 		$221K Sell
6,420
-680
-10% -$20.8K 0.04% 305
2019
Q3 		$215K Sell
7,100
-729
-9% -$18.9K 0.04% 293
2019
Q2 		$207K Buy
+7,829
New +$199K 0.04% 289
2019
Q1 		– Sell
-10,501
Closed -$242K – 331
2018
Q4 		$242K Sell
10,501
-3,847
-27% -$75.4K 0.05% 278
2018
Q3 		$322K Buy
14,348
+6,399
+81% +$122K 0.06% 243
2018
Q2 		$132K Buy
7,949
+1,719
+28% +$26.2K 0.03% 384
2018
Q1 		$88K Buy
+6,230
New +$92K 0.02% 494

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Mount Yale Investment Advisors's HZNP Position: Q1 2023 in Review

Mount Yale Investment Advisors sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 9,236 shares — an estimated $1.05M sold.

Mount Yale Investment Advisors first reported a position in HZNP in Q1 2018 and held it in 19 quarters. The position peaked at $1.33M in Q3 2021. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

  • Mount Yale Investment Advisors reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • Mount Yale Investment Advisors sold 9,236 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $1.05M.
  • Mount Yale Investment Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2018 and held it in 19 quarters.
  • Mount Yale Investment Advisors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.33M in Q3 2021.
  • 553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Mount Yale Investment Advisors's 13F filing for Q1 2023, filed 11 May 2023.